Related Experiment Video
Updated: Sep 27, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Myosin light chain kinase inhibitors induce retraction of mature oligodendrocyte processes
María G Thomas1, Tomás A Santa Coloma, Jorge Correale
1IIB Fundación Campomar, IIB FCEyN, University of Buenos Aires and IIBBA-CONICET, Buenos Aires, Argentina.
Abstract:
Mature oligodendrocytes emit numerous myelinating processes. Force generating molecules are required for process outgrowth and spreading. We have analyzed the effect of the myosin II light chain kinase inhibitors ML-7 and ML-9 in cultured oligodendrocytes. Both drugs affect oligodendrocyte cell shape, provoking a retraction of high order processes. Our results suggest that the adhesion of the myelinating processes to the substrate depends on MLC phosphorylation, thus likely implicating myosin IIA.
Insights
Myosin II light chain kinase inhibitors ML-7 and ML-9 alter oligodendrocyte cell shape. These findings suggest that myosin IIA is involved in the adhesion of myelinating processes to the substrate.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mature oligodendrocytes extend numerous myelinating processes essential for nerve insulation.
- Process outgrowth and spreading rely on force-generating molecular mechanisms.
- Myosin II, a motor protein, is implicated in cellular shape dynamics.
Purpose of the Study:
- To investigate the role of myosin II light chain kinase (MLCK) in oligodendrocyte process morphology.
- To determine the effect of MLCK inhibitors ML-7 and ML-9 on cultured oligodendrocytes.
Main Methods:
- Primary oligodendrocyte cultures were treated with ML-7 and ML-9.
- Changes in oligodendrocyte cell shape and process morphology were analyzed.
Main Results:
- MLCK inhibitors ML-7 and ML-9 induced significant alterations in oligodendrocyte cell shape.
- Both drugs caused a retraction of high-order myelinating processes.
- Results suggest that MLC phosphorylation is crucial for process adhesion.
Conclusions:
- Myosin IIA likely plays a critical role in mediating the adhesion of myelinating processes to the substrate.
- Inhibition of MLCK affects oligodendrocyte process stability and morphology.
More Related Videos
10:45Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization
Published on: January 13, 2012
11:11Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
Related Concept Videos
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Drugs that Stabilize Microtubules
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...